IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q2 2018 Holdings

Filed 2018-08-14 | 3 holdings | $6.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Onconova Therapeutics IncCOM NEW68232V306$5.0K12,244,08071.9%
MMA Cap Mgmt LLC(MMAC)COM55315D105$1.9K72,55228.0%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$5390,6240.1%